Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Collaboration revenue	$ 80,000	$ 2,805
Operating expenses:
Research and development	63,386	71,801
General and administrative	36,448	41,668
Restructuring expenses	2,063	0
Total operating expenses	101,897	113,469
Loss from operations	(21,897)	(110,664)
Other income, net	12,172	13,329
Net loss	$ (9,725)	$ (97,335)
Net loss per share, Basic	$ (0.16)	$ (1.59)
Net loss per share, diluted	$ (0.16)	$ (1.59)
Weighted Average Number of Shares Outstanding, Diluted	61,984	61,310
Weighted Average Number of Shares Outstanding, Basic	61,984	61,310
Comprehensive loss:
Net Income (Loss)	$ (9,725)	$ (97,335)
Other comprehensive gain:
Unrealized gain on marketable securities	266	661
Total other comprehensive gain	266	661
Comprehensive loss	$ (9,459)	$ (96,674)